Conformational landscape of selective μ-opioid agonists in gas phase and in aqueous solution: The fentanyl series

Drug Design and Discovery

Volumn 17, Issue 1, 2000, Pages 55-67

  Subramanian, Govindan ^a   Ferguson, David M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Agonists; Bioactive conformation; Fentanyl; MD simulations; Opioid ligands; Pharmacophore

Indexed keywords

DRUG ANALOG; FENTANYL; MU OPIATE RECEPTOR AGONIST;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; DRUG CONFORMATION; MOLECULAR DYNAMICS; STRUCTURE ACTIVITY RELATION;

ANALGESICS, OPIOID; FENTANYL; MOLECULAR CONFORMATION; RECEPTORS, OPIOID, MU; SOLUTIONS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034088315     PISSN: 10559612     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Janssen, P. A. J. (1962). A review of the chemical features associated with strong morphine-like activity, Brit. J Anaseth , 34, 260-268.
2. (a) Helsley, G. C., Lunsford, C. D., Welstead, Jr., W. J, Boswell, Jr, R. R, Funderburk, W. H. and Johnson, D. N. (1969). Synthesis and analgetic activity of some 1-substituted 3-pyrrolidinylanilides and dihydrobenzoxazinones, J. Med. Chem., 12, 583-586;
3. (b) van Bever, W F M, Niemegeers, C J. E and Janssen, P A. J. (1974). Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of W-[3-methyl-I-(2-phenylethyI)-4-piperidyl]-N-phenylpropanamide and N-[3-methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl]-N-phenylpropanamide, J. Med Chem., 17, 1047 - 1051;
4. (c) Borne, R F, Law, S.-J., Kapeghian, J. C. and Masten, L W. (1980). Evaluation of 2-azabicyclo[2.2.2]octane analogs of 4-anilidopiperidine analgesics, J. Pharm. Sci. 69, 1104 - 1106;
5. (d) Finney, Z G. and Riley. T N. (1980). 4-Anilidopiperidine analgesics. 3. 1-substituted 4-(propananilido)perhydroazepines as ring-expanded analogues, J. Med. Chem , 23, 895 - 899;
6. (e) Maryanoff, B. E., Simon, E J., Gioannini, T. and Gorissen, H (1982). Potential affinity labels for the opiate receptor based on fentanyl and related compounds, J. Med. Chem., 25, 913-919.
7. (f) Colapret, J. A, Diamantidis, G., Spencer, H. K., Spaulding, T. C. and Rudo, F. G. (1989) Synthesis and pharmacological evaluation of 4,4-disubstituted piperidines, J Med Chem, 32, 968 - 974;
8. (g) France, C.P. Winger, G., Medzihradsky, F, Seggel, M. R., Rice, K. C. and Woods. J. H. (1991). Mirfentanil Pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects, J Pharm. Exp Ther., 258, 502 - 510;
9. (h) Feldman. P. L., James, M. K., Brackeen, M F., Bilotta, J.M., Schuster, S.V, Lahey, A P, Lutz, M W, Johnson, M. R. and Leighton, H. J. (1991). Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics, J. Med. Chem., 34, 2202 - 2208 and references cited therein;
10. (i) Femández, M. J., Huertas, R. M., Gálvez, E., Orjales, A., Berisa, A., Labeaga, L., Gago, F., Fonseca, I., Sanz Aparicio, J., Cano, F. H., Albert, A. and Fayos, J. (1992). Synthesis, and structural, conformational and phar-macological studies of new fentanyl derivatives of the norgranatane system, J. Chem. Soc., Perkin Trans 2, 687 - 694;
11. (j) France, C. P., Gerak, L. R., Flynn, D., Winge, G. D., Madzihradsky, F., Bagley, J. R., Brockunier, L. L. and Woods, J. H. (1995). Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys, J. Pharm. Exp. Ther., 274, 17-28.
12. (a) Heerding, J., Raynor. K., Kong, H., Yu, L. and Reisine. T. (1994). Mutagenesis reveals that agonists and peptide antagonists bind in fundamentally distinct manners to the rat mu receptor than do nonpeptide antagonists. Reg. Pep., 54, 119-120;
13. (b) Zhu, J., Xue, J.-C., Law, P-Y., Claude, P. A., Luo, L.-Y., Yin, J.-L., Chen, C.-G. and Liu-Chen, L.-Y. (1996). The region in the μ opioid receptor conferring selectivity for sufentanil over the d receptor is different from that over the κ receptor, FEBS Lett., 384, 198-202;
14. (c) Mansour, A., Taylor, L.P., Fine, J.L., Thompson, R. C., Hoversten, M. T., Mosberg, H. I., Watson, S. J. and Akil, H. (1997). Key residues defining the μ-opioid receptor binding pocket; A site-directed mutagenesis study, J. Neurochem., 68, 344-353;
15. (d) Lu, Y-F., Xu, H., Liu-Chen, L.-Y. Chen, C.-G., Partilla, J. S., Brine, G. A., Carroll, F. I., Rice, K. C., Lai, J., Porreca, F., Sadee, W. and Rothman, R. B. (1998) Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat μ opioid receptor. Synapse, 28, 117 - 124.
16. Rong, S.-B., Zhu, Y.-C., Jiang, H.-L., Wang, Q.-M., Zhao, S.-R., Chen, K.-X. and Ji, R.-Y. (1997). Interaction models of 3-methylfentanyl derivatives with μ-opioid receptors, Acta Pharm. Sin., 18, 128 - 132.
17. (a) Martin, Y. C. (1998). 3D QSAR; Current state, scope, and limitations, Pers. Drug Dis. Design, 12-14, 3-23.
18. (b) Dunn III, W. J. and Hopfinger, A. J (1998). 3D QSAR of flexible molecules using tensor representation, Pers. Drug Dis. Design, 12 - 14, 167 - 182.
19. Tollenaere. J. P., Moereels, H. and van Loon, M. (1986). On conformation analysis, molecular graphics, fentanyl and its derivatives, Prog. Drug Res., 30, 92 - 126.
20. Martin, J. and Andrews, P. (1987). Conformation-activity relationships of opiate analgesics, J. Comp. -Aided Mol Design, 1, 53 - 72.
21. Brandt, W., Barth, A. and Höltje, H.-D. (1993). A new consistent model explaining structure (conformation)-activity relationships of opiates with μ-selectivity, Drug Des. Dis., 10, 257-283.
22. Cometta-Morini, C., Maguire, P. A. and Loew, G. H. (1992). Molecular Determinants of μ receptor recognition for the fentany! class of compounds, Mol. Pharmacol., 41, 185-196.
23. Cometta-Morini, C. and Loew, G. H. (1991). Development of a conformational search strategy for flexible ligands; A study of the potent μ-selective opioid analgesic fentanyl, J. Comp. -Aided Mol. Design. 5, 335-356.
24. (a) van Bever, W. F. M., Niemegeers, C. J. E., Schellekens, K. H. L. and Janssen, P. A J. (1976). N-4-substituted 1 -(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely, potent analgesics with unusually high safety margin, Arzneim-Forsch., 26, 1548- 1551;
25. (b) van Daele, P. G. H., DeBruyn, M. F. L., Boey, J. M., Sanczuk, S., Agten, J. T. M. and Janssen, P. A. J. (1976). Synthetic analgesics. N-(1-[2-arylethyl]-4-substituted 4-piperidinyl) N-arylalkanamides, Arzneim. -Forsch., 26, 1521-1526;
26. (c) Kudzma, L. V, Sevemak, S. A., Benvenga, M. J., Ezell, E. R, Ossipov, M. H., Knight, V. V., Rudo, F. G., Spencer, H. K. and Spaulding, T. C. (1989). 4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents, J. Med. Chem., 32, 2534-2542.
27. (a) Band, L., Xu, H., Bykov, V., Greig, N., Kim, C.-H., Newman, A., Jacobson. A. E., Rice, K. C. and Rothman, R. B. (1990). The potent opioid agonist, (+)-cis-3-methylfentanyl bind pseudoirreversibly to the opioid receptor complex in vitro and in vivo: Evidence for a novel mechanism of action, Life Sd., 47, 2231-2240;
28. (b) Xu, H., Kim, C.-H., Zhu, Y. C., Weber, R. J., Jacobson, A. E., Rice, K. C. and Rothman, R. B. (1991). (+)-cis-3-methylfentanyl and its analogs bind pseudoirreversibly to the mu opioid binding site: Evidence for pseudoal-losteric modulation, Neuropharmacology, 30, 455-462;
29. (c) Wang, Z.-X., Zhu, Y.-C., Chen, Z.-J. and Ji, R.-Y. (1993). Stereoisomers of 3-methylfentanyl: Synthesis, abso-lute configuration and analgesic activity, Acta Pharm. Sin., 28, 905-910.
30. 33S]GTP-y-S binding using cloned p-opioid receptors, Analgesia. 3. 35-42.
31. (a) Xu, H., Chen, J. and Chi, Z.-Q. (1985). Ohmefentanyl-A new agonist for μ-opiate receptor, Sci. Sin., 28, 504-511;
32. (b) Brine, G A., Stark, P. A., Carroll, F. I., Xu, H. and Rothman, R. B. (1992). Enantiomers of (±)-cis-N-[1-(2-hydroxy-2-phenethy)-3-methyl-4-piperidyl]-N- phenylpropanamide: Influences of the hydroxyl group. Med Chem. Res., 2, 34-40;
33. (c) Ni, Q., Xu, H., Partilla, J. S., Stark, P. A , Carroll, F. I., Brine, G. A. and Rothman, R. B. (1993). Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3-methylfentanyl congeners, RTI-46144-and its enantiomers: Evidence for different bind-ing domains, Synapse, 15, 296-306;
34. (d) Wang, Z.-X., Zhu, Y.-C., Chen, X.-J. and Ji, R.-Y. (1994). Ohmefentanyl enantiomers and its analgesic activity, Chi. Sci. Bull., 9, 2004-2008;
35. (e) Wang, Z.-X., Zhu, Y-C., Jin, W.-Q., Chen, X.-J., Chen, J., Ji, R.-Y. and Chi, Z.-Q. (1995). Stereoisomers of N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidyl]-N-phenylpropanamide- Synthesis, stereochemistry, analgesic activity, and opioid receptor binding characteristics, J. Med. Chem., 38, 3652-3659;
36. (f) Lu, Y.-F., Xu, H., Partilla, J. S., Brine, G. A., Carroll, F. I., Rice, K. C., Sadee, W. and Rothman, R. B. (1996). Opioid peptide receptor studies. 5. Further evidence that the methylfentanyl congener RTI-4614-4 and its four Stereoisomers bind to different domains of the rat μ-opioid receptor. Analgesia. 2, 291-297.
37. Peeters, O. M., Blaton, N. M., DeRanter, C. J., van Herk, A. M. and Goubitz, K. (1979). Crystal and molecular structure of N-[1-(2-phenethyl)-4-piperidinylium]-N-phenylpropanamide (fentanyl) citrate-toluene sol-vate, J. Ctyst. Mol. Str., 9. 153-161.
38. Kock, M. H. J., DeRanter, C. J., Robies, M. and Dideberg. O. (1976) Acta Cryst., B32, 2529.
39. Flippen-Anderson, J. L. George, C, Bertha, C. M. and Rice, K. C. (1994) X-ray crystal structures of potent opioid receptor ligands: Etonitazene, cis-(+)-3-methylfentanyl, etorphine, diprenorphine, and buprenorphine, Heterocydes, 39, 751-766.
40. Michel, A., Lebrun, B , Evrard, G. and Durant, F. (1982). Structure of N-[1-(2-hydroxy-2-phenethyl)-4-piperidyl]-N-phenylpropanarmide hydrochloride (R4333*), an analgesic of the fentanyl family, Acta. Cryst. B38, 2961 - 2963.
41. Brine, G. A., Stark, P A, Liu, Y. Carroll, F. L, Singh, P., Xu, H. and Rothman, R. B. (1995) Enantiomers of diastereomeric cis-N-[1-(2-hydroxy-2-phenylethyl)-3-meth-yl-4-piperidyl]-N-phenylpropanamide: Synthesis, x-ray analysis, and biological activities, J Med Chem , 38, 1547-1557.
42. Bagley, J. R., Thomas, S. A., Rudo, F. G., Spencer, H. K, Doorley, B. M., Ossipov, M. H., Jerussi, T P., Benvenga, M. J. and Spaulding, T. (1991) New 1-(heterocyclylalkyl)-4-(propionanilido)-4-pineridmyl methyl ester and methylene methyl ether analgesics, J Med. Chem., 34, 827 - 841
43. Frisch, M. J., Trucks, G. W, Schlegel, H B., Gill, P M W., Johnson, B. G., Robb, M. A., Cheeseman, J. R., Keith, T., Petersson, G. A., Montgomery, J A., Raghavachari, K., Al-Laham, M.A., Zakrzewski, V. G.. Ortiz, J. V, Foresman, J. B., Cioslowski, J., Stefanov, B. B . Nanayakkara, A., Challacombe. M., Peng. C. Y., Ayala, P Y., Chen, W, Wong, M W., Andres, J. L, Replogle, E. S., Gomperts, R , Martin, R. L., Fox, D. J., Binkley, J. S DeFrees, D. J., Baker, JL, Stewart, J. J. P, Head-Gordon, M., Gonzalez, C. and Pople, J. A. (1995) Gaussian 94. Revision E2, Gaussian Inc., Pittsburgh, PA
44. Cieplak, P., Cornell, W. D . Bayly, C. and Kollman, P. A. (1995) Application of the multimolecule and multiconformational RESP methodology to biopolymers: Charge derivation for DNA, RNA, and proteins, J Comput Chem., 16, 1357-1377.
45. (a) Pearlman, D. A., Case, D. A., Caldwell, J. W., Ross, W S, Cheatham III, T. E, Debolt, S., Ferguson, D. M., Seibel, G L. and Kollman, P. A. (1995). AMBER, a package of computer programs for applying molecular mechanics, normal-mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules, Comput Phys. Commun., 91, 1-41;
46. (b) Pearlman, D A, Case, D. A , Caldwell, J. W., Ross, W. S., Cheatham III, T E., Ferguson, D. M., Seibel, G. L., Singh, U C , Weiner, P. K. and Kollman, P A. (1995) AMBER, Version 4.1, Department of Pharmaceutical Chemistry. University of California. San Francisco, CA.
47. Cornell, W. D, Cieplak. P., Bayly, C. I., Could, I R, Merz, Jr., K M., Ferguson, D M. Spellmeyer, D. C., Fox. T., Caldwell, J W and Kollman, P. A (1995). A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am Chem Soc., 117, 5179-5197.
48. a) Casy. A. F, Hassan. M M A., Simmonds, A B and Staniforth, D. (1969) Structure-activity relations in analgesics based on 4-anilmopiperidine. J. Pharm Pharmac., 21, 434-440,
49. (b) Castiglione-Morelh, M. A.. Lelj. F, Pastore, A., Salvadon, S., Tancredi, T. Tomatis, R. and Trivellone, E (1987). A 500-MHz proton nuclear magnetic resonance study of μ opioid peptides in a simulated receptor environment. J. Med Chem., 30, 2067-2073:
50. (C) Brine, G. A , Boldt, K. G., Huang, P-T, Sawyer, D K and Carroll, F. I (1989). Carbon-13 nuclear magnetic resonance spectra of fentanyl analogs, J Heteroo-cyclic Chem. 26, 677-686.
51. Riley T. N. and Bagley, J. R. (1979). 4-Anilidopiperidine analgesics 2 A study of ihe conformational aspects of the analgesic activity of the 4-anilidopipendines utilizing isomeric N-substituted 3-(propananilido)nortropane analogues, J, Med. Chem,22, 1167-1171
52. Jorgenson, W. L., Chandrasekhar, J., Madhura, J D., Impey, R. W. and Klein, M, L. (1983), Comparison of simple potential functions for simulating liquid water, J. Chem. Phys., 79, 926-935.
53. Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. E, DiNola, A. and Haak, J R. (1984). Molecular dynamics with coupling to an external bath, J. Chem Phys., 81, 3684-3690.
54. -)
55. Urban, J J., Cronin, C. W., Roberts, R. R. and Famini, G. R. (1997). Conformational preferences of 2-phenethylamines. A computational study of substituent and solvent effects on the intramolecular amine-aryl inter-actions in charged and neutral 2-phenethylamines, J Am. Chem. Soc., 119, 12292-12299 and references cited therein.
56. Maryanoff, B. E., McComsey, D. F. Taylor, Jr., R. J and Gardocki, J. F. (1981). Synthesis and stereochemistry of 7 phenyl-2-propionanilidobenzo[a]qumohzidine derivatives. Structural probes of fentanyl analgesics, J. Med. Chem., 24, 79-88.
57. Nagy, PI , Alagona, G and Ghio, C. (1999). Theoretical studies on the conformation of protonated dopamine in gas phase and in aqueous solution, J. Am. Chem Soc., 121, 4804-4815 and references cited therein.
58. Berger, J. G., Davidson, F. and Langford, G. E. (1977). Synthesis of some conformationally restricted analogues of fentanyl, J. Med. Chem., 20, 600-602
59. Pogozheva, I. D , Lomize, A. L. and Mosberg, A. I (1998). Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints, Biophys. J., 75, 612-634.
60. Bagley, J. R., Wynn, R. L., Rudo, F. G., Doorley, B. M, Spencer, H. K. and Spaulding, T. (1989) New 4-(hetero-anilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties, J, Med. Chem., 32, 663-671
61. (a) Lalinde, N., Moliterni, J., Wright, D., Spencer. H. K., Ossipov, M. H., Spaulding, T. C. and Rudo. F G (1990). Synthesis and pharmacological evaluation of a series of new 3-methyl-1,4-disubstituted-pipendine analgesics, J. Med. Chem., 33, 2876-2882;
62. (b) Brine, G. A., Stark, P. A., Carroll, F I., Xu, H., Lewis, B. and Rothman, R B. (1992). Amide analogs of (±)-cis-N-[l-(2-hydrox>-2-phenylethyl)-3-methyl-4-pipendyl]-N- phenylpropanamide: Highly selective ligands for the mu opioid binding site, Med. Chem. Res., 2, 41-47.
63. Borne. R R, Fifer. E. K and Waters, I W. (1984) Conformationally restrained fentanyl analogues. 2. Synthesis and analgetic evaluation of perhydro-1,6-naphthyndin-2-ones, J Med Chem , 27, 1271-1275.
64. Li, J.-G, Raffa, R B., Cheung, P, Tzeng, T-B. and Liu-Chen, L-Y. (1998). Apparent thermodynamic parameters of ligand binding to the cloned rat ̃-opioid receptor, Eur. J Pharmacol. 354, 227-237
65. Subramanian, G., Ferguson. D. M., Paterlint, G M. and Portoghese, P S. (2000). Molecular docking reveals a novel binding site model for fentanyls at the μ-receptor, J. Med Chem , 43, 000-000